RXD vs. BBH
RXD (ProShares UltraShort Health Care) and BBH (VanEck Vectors Biotech ETF) are both exchange-traded funds - RXD is a Leveraged Equities fund tracking the DJ Global United States (All) / Health Care -IND (-200%), while BBH is a Health & Biotech Equities fund tracking the MVIS US Listed Biotech 25 Index. Both are passively managed. Over the past 10 years, RXD returned -20.50%/yr vs 7.88%/yr for BBH. At a correlation of -0.68, they often move in opposite directions. RXD charges 0.95%/yr vs 0.35%/yr for BBH.
Performance
RXD vs. BBH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RXD achieves a -1.40% return, which is significantly lower than BBH's 3.83% return. Over the past 10 years, RXD has underperformed BBH with an annualized return of -20.50%, while BBH has yielded a comparatively higher 7.88% annualized return.
RXD
- 1D
- -3.08%
- 1M
- -9.66%
- YTD
- -1.40%
- 6M
- 0.04%
- 1Y
- -25.85%
- 3Y*
- -8.16%
- 5Y*
- -7.55%
- 10Y*
- -20.50%
BBH
- 1D
- 0.79%
- 1M
- 6.81%
- YTD
- 3.83%
- 6M
- 1.68%
- 1Y
- 29.45%
- 3Y*
- 8.59%
- 5Y*
- 0.12%
- 10Y*
- 7.88%
RXD vs. BBH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RXD ProShares UltraShort Health Care | -1.40% | -21.66% | 4.83% | 3.25% | 1.20% | -37.97% | -44.25% | -32.44% | -14.33% | -35.24% |
BBH VanEck Vectors Biotech ETF | 3.83% | 21.18% | -4.29% | 3.94% | -15.25% | 11.81% | 22.13% | 26.34% | -10.70% | 16.46% |
Correlation
The correlation between RXD and BBH is -0.77, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.77 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.73 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.74 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.70 |
Correlation (All Time) Calculated using the full available price history since Feb 1, 2007 | -0.68 |
The correlation between RXD and BBH has been stable across timeframes, ranging from -0.77 to -0.68 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RXD vs. BBH — Risk / Return Rank
RXD
BBH
RXD vs. BBH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Health Care (RXD) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RXD | BBH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.39 | ||
| Sortino ratioReturn per unit of downside risk | -3.31 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.27 | -0.39 |
| Calmar ratioReturn relative to maximum drawdown | -0.75 | 2.81 | -3.55 |
| Martin ratioReturn relative to average drawdown | -1.12 | 6.74 | -7.86 |
Loading charts...
Drawdowns
RXD vs. BBH - Drawdown Comparison
The maximum RXD drawdown since its inception was -99.65%, which is greater than BBH's maximum drawdown of -72.70%. Use the drawdown chart below to compare losses from any high point for RXD and BBH.
Loading charts...
Drawdown Indicators
| RXD | BBH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.65% | -72.70% | -26.95% |
Max Drawdown (1Y)Largest decline over 1 year | -34.63% | -10.55% | -24.08% |
Max Drawdown (3Y)Largest decline over 3 years | -36.60% | -22.74% | -13.86% |
Max Drawdown (5Y)Largest decline over 5 years | -40.50% | -39.86% | -0.64% |
Max Drawdown (10Y)Largest decline over 10 years | -90.64% | -39.86% | -50.78% |
Current DrawdownCurrent decline from peak | -99.63% | -8.82% | -90.81% |
Average DrawdownAverage peak-to-trough decline | -81.91% | -20.73% | -61.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.10% | 4.38% | +18.72% |
Volatility
RXD vs. BBH - Volatility Comparison
ProShares UltraShort Health Care (RXD) has a higher volatility of 10.55% compared to VanEck Vectors Biotech ETF (BBH) at 6.43%. This indicates that RXD's price experiences larger fluctuations and is considered to be riskier than BBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RXD | BBH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.55% | 6.43% | +4.12% |
Volatility (6M)Calculated over the trailing 6-month period | 21.92% | 14.58% | +7.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.33% | 19.32% | +11.01% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.91% | 21.47% | +8.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.01% | 22.12% | +10.89% |
RXD vs. BBH - Expense Ratio Comparison
RXD has a 0.95% expense ratio, which is higher than BBH's 0.35% expense ratio.
Dividends
RXD vs. BBH - Dividend Comparison
RXD's dividend yield for the trailing twelve months is around 3.01%, more than BBH's 0.49% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.49% | 0.51% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
RXD ProShares UltraShort Health Care | 3.01% | 3.29% | 4.36% | 3.17% | 0.67% | 0.00% | 0.17% | 1.73% | 0.22% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
RXD and BBH have a correlation of -0.77, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RXD has higher volatility (10.55%) compared to BBH (6.43%). In terms of maximum drawdown, RXD dropped -99.65% vs BBH's -72.70%.
On 10-year performance, BBH leads with 7.88% vs -20.50% for RXD. On fees, BBH is cheaper at 0.35% per year. On volatility, BBH has been the lower-risk option at 6.43%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, BBH has performed better with a 7.88% return vs -20.50%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BBH is cheaper with a 0.35% expense ratio, compared with 0.95% for RXD.
RXD has the higher dividend yield at 3.01%, compared with 0.49% for BBH.
RXD is categorized as Leveraged Equities, while BBH is Health & Biotech Equities. RXD tracks DJ Global United States (All) / Health Care -IND (-200%), while BBH tracks MVIS US Listed Biotech 25 Index. They also come from different issuers: ProShares and VanEck. Their fees differ too: 0.95% for RXD and 0.35% for BBH.
BBH currently has the higher Sharpe Ratio (1.53 vs -0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RXD and BBH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer